186 related articles for article (PubMed ID: 12154404)
41. Promoter hypermethylation profile of kidney cancer.
Dulaimi E; Ibanez de Caceres I; Uzzo RG; Al-Saleem T; Greenberg RE; Polascik TJ; Babb JS; Grizzle WE; Cairns P
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3972-9. PubMed ID: 15217927
[TBL] [Abstract][Full Text] [Related]
42. Chemically induced DNA hypomethylation in breast carcinoma cells detected by the amplification of intermethylated sites.
Sadikovic B; Haines TR; Butcher DT; Rodenhiser DI
Breast Cancer Res; 2004; 6(4):R329-37. PubMed ID: 15217500
[TBL] [Abstract][Full Text] [Related]
43. Identification of DNA methylation in 3' genomic regions that are associated with upregulation of gene expression in colorectal cancer.
Smith JF; Mahmood S; Song F; Morrow A; Smiraglia D; Zhang X; Rajput A; Higgins MJ; Krumm A; Petrelli NJ; Costello JF; Nagase H; Plass C; Held WA
Epigenetics; 2007 Sep; 2(3):161-72. PubMed ID: 17965620
[TBL] [Abstract][Full Text] [Related]
44. [Effect of aberrant DNA methylation on the expression of cancer-related genes in Cd-transformed cells].
Lei YX; Joseph P; Wu ZL; Ong TM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2003 Apr; 21(2):114-6. PubMed ID: 14761530
[TBL] [Abstract][Full Text] [Related]
45. DNA motifs associated with aberrant CpG island methylation.
Feltus FA; Lee EK; Costello JF; Plass C; Vertino PM
Genomics; 2006 May; 87(5):572-9. PubMed ID: 16487676
[TBL] [Abstract][Full Text] [Related]
46. Molecular diagnostic applications of DNA methylation technology.
Cottrell SE
Clin Biochem; 2004 Jul; 37(7):595-604. PubMed ID: 15234241
[TBL] [Abstract][Full Text] [Related]
47. Preference of DNA methyltransferases for CpG islands in mouse embryonic stem cells.
Hattori N; Abe T; Hattori N; Suzuki M; Matsuyama T; Yoshida S; Li E; Shiota K
Genome Res; 2004 Sep; 14(9):1733-40. PubMed ID: 15310660
[TBL] [Abstract][Full Text] [Related]
48. Methylated genes as new cancer biomarkers.
Duffy MJ; Napieralski R; Martens JW; Span PN; Spyratos F; Sweep FC; Brunner N; Foekens JA; Schmitt M;
Eur J Cancer; 2009 Feb; 45(3):335-46. PubMed ID: 19138839
[TBL] [Abstract][Full Text] [Related]
49. New approach for detection of amplification in cancer DNA using restriction landmark genomic scanning.
Hirotsune S; Hatada I; Komatsubara H; Nagai H; Kuma K; Kobayakawa K; Kawara T; Nakagawara A; Fujii K; Mukai T
Cancer Res; 1992 Jul; 52(13):3642-7. PubMed ID: 1617637
[TBL] [Abstract][Full Text] [Related]
50. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer.
Yang Q; Nakamura M; Nakamura Y; Yoshimura G; Suzuma T; Umemura T; Shimizu Y; Mori I; Sakurai T; Kakudo K
Clin Cancer Res; 2002 Sep; 8(9):2890-3. PubMed ID: 12231533
[TBL] [Abstract][Full Text] [Related]
51. [Global DNA hipomethylation--the meaning in carcinogenesis].
Guz J; Foksiński M; Oliński R
Postepy Biochem; 2010; 56(1):16-21. PubMed ID: 20499677
[TBL] [Abstract][Full Text] [Related]
52. Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed acute myeloid leukemia; involvement of the WIT-1 gene.
Plass C; Yu F; Yu L; Strout MP; El-Rifai W; Elonen E; Knuutila S; Marcucci G; Young DC; Held WA; Bloomfield CD; Caligiuri MA
Oncogene; 1999 May; 18(20):3159-65. PubMed ID: 10340388
[TBL] [Abstract][Full Text] [Related]
53. DNA methylation profiling in cancer.
Kondo Y; Issa JP
Expert Rev Mol Med; 2010 Jul; 12():e23. PubMed ID: 20663272
[TBL] [Abstract][Full Text] [Related]
54. Genome aberrations observed by restriction landmark genome scanning analysis of chromosomal DNA in various types of primary hepatocellular carcinoma.
Hanafusa T; Yumoto Y; Mimura T; Shinji T; Hada H; Koide N; Tsuji T
Hepatogastroenterology; 2002; 49(44):482-6. PubMed ID: 11995478
[TBL] [Abstract][Full Text] [Related]
55. Combined restriction landmark genomic scanning and virtual genome scans identify a novel human homeobox gene, ALX3, that is hypermethylated in neuroblastoma.
Wimmer K; Zhu Xx XX; Rouillard JM; Ambros PF; Lamb BJ; Kuick R; Eckart M; Weinhäusl A; Fonatsch C; Hanash SM
Genes Chromosomes Cancer; 2002 Mar; 33(3):285-94. PubMed ID: 11807986
[TBL] [Abstract][Full Text] [Related]
56. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies.
Smiraglia DJ; Rush LJ; Frühwald MC; Dai Z; Held WA; Costello JF; Lang JC; Eng C; Li B; Wright FA; Caligiuri MA; Plass C
Hum Mol Genet; 2001 Jun; 10(13):1413-9. PubMed ID: 11440994
[TBL] [Abstract][Full Text] [Related]
57. Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning.
Wang SS; Smiraglia DJ; Wu YZ; Ghosh S; Rader JS; Cho KR; Bonfiglio TA; Nayar R; Plass C; Sherman ME
Cancer Res; 2008 Apr; 68(7):2489-97. PubMed ID: 18381458
[TBL] [Abstract][Full Text] [Related]
58. Epigenetic gene deregulation in cancer.
Malik K; Brown KW
Br J Cancer; 2000 Dec; 83(12):1583-8. PubMed ID: 11104550
[TBL] [Abstract][Full Text] [Related]
59. Genome-wide methylation analysis.
Unterberger A; Dubuc AM; Taylor MD
Methods Mol Biol; 2012; 863():303-17. PubMed ID: 22359302
[TBL] [Abstract][Full Text] [Related]
60. A bird's eye view of global methylation.
Eng C; Herman JG; Baylin SB
Nat Genet; 2000 Feb; 24(2):101-2. PubMed ID: 10655046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
